These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4085500)

  • 1. Characterization of the deoxynucleoside-dependent reversal of hypoxia-induced inhibition of cell cycle progression in Ehrlich ascites tumor cells.
    Löffler M
    Eur J Cell Biol; 1985 Nov; 39(1):198-204. PubMed ID: 4085500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards a further understanding of the growth-inhibiting action of oxygen deficiency. Evaluation of the effect of antimycin on proliferating Ehrlich ascites tumour cells.
    Löffler M
    Exp Cell Res; 1985 Mar; 157(1):195-206. PubMed ID: 3972010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further characterization of the growth inhibitory effect of rotenone on in vitro cultured Ehrlich ascites tumour cells.
    Löffer M; Schneider F
    Mol Cell Biochem; 1982 Oct; 48(2):77-90. PubMed ID: 7144746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restimulation of cell cycle progression by hypoxic tumour cells with deoxynucleosides requires ppm oxygen tension.
    Löffler M
    Exp Cell Res; 1987 Mar; 169(1):255-61. PubMed ID: 3102268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle kinetics and metabolism of Ehrlich ascites tumor cells in the presence of chloramphenicol as inhibitor of mitochondrial protein synthesis.
    Kroll W; Schneider F
    Z Naturforsch C Biosci; 1984; 39(1-2):126-35. PubMed ID: 6720024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morphometric characteristics and functional activity of the cells of Ehrlich ascites cancer found in different phases of the cell cycle].
    Nikitchenko VV; Danko IM; Andrushchak LI; Teplitskiĭ MG; Kaz'min SD
    Eksp Onkol; 1989; 11(1):31-5. PubMed ID: 2924706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle phase-dependent induction of ornithine decarboxylase-antizyme.
    Linden M; Anehus S; Långström E; Baldetorp B; Heby O
    J Cell Physiol; 1985 Nov; 125(2):273-6. PubMed ID: 4055911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor agents XLI: Effects of eupaformosanin on nucleic acid, protein, and anaerobic and aerobic glycolytic metabolism of Ehrlich ascites cells.
    Hall IH; Lee KH; Williams WL; Kimura T; Hirayama T
    J Pharm Sci; 1980 Mar; 69(3):294-7. PubMed ID: 7381705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth characteristics of anaerobically treated Ehrlich ascites tumor cells after reaeration as studied by combination of flow cytometry and centrifugal elutriation.
    Merz R; Schneider F
    Z Naturforsch C Biosci; 1982 Sep; 37(9):833-8. PubMed ID: 7136187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of zinc deficiency on cellular processes and morphology in Ehrlich ascites tumor cells.
    Saryan LA; Minkel DT; Dolhun PJ; Calhoun BL; Wielgus S; Schaller M; Petering DH
    Cancer Res; 1979 Jul; 39(7 Pt 1):2457-65. PubMed ID: 445446
    [No Abstract]   [Full Text] [Related]  

  • 11. Growth characteristics of in vitro cultured Ehrlich ascites tumor cells under anaerobic conditions and after reaeration.
    Merz R; Schneider F
    Z Naturforsch C Biosci; 1982; 37(3-4):326-34. PubMed ID: 7072316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the role of dihydroorotate dehydrogenase in growth cessation of Ehrlich ascites tumor cells cultured under oxygen deficiency.
    Löffler M
    Eur J Biochem; 1980; 107(1):207-15. PubMed ID: 6249586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor agents XXIX: Effects of eupahyssopin on nucleic acid, protein, anaerobic, and aerobic metabolism of Ehrlich ascites tumor cells.
    Hall IH; Lee KH; Eigebaly SA
    J Pharm Sci; 1978 Sep; 67(9):1232-5. PubMed ID: 690825
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytokinetic studies on the switch from glucose to uridine metabolism, and vice versa, of Ehrlich ascites tumour cells in vitro.
    Löffler M; Wenzel A; Schneider F
    Cell Tissue Kinet; 1987 Mar; 20(2):181-90. PubMed ID: 3607842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible G2 block in the cell cycle of Ehrlich ascites carcinoma cells.
    Lazebnik YA; Medvedeva ND; Zenin VV
    Exp Cell Res; 1991 Jul; 195(1):247-54. PubMed ID: 2055271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition by sorbylhydroxamic acid of deoxyribonucleic acid synthesis in Ehrlich ascites tumor cells.
    Gale GR; Smith AB; Walker EM
    Cancer Res; 1970 Jan; 30(1):24-9. PubMed ID: 5441077
    [No Abstract]   [Full Text] [Related]  

  • 17. Discontinuous RNA and protein synthesis and accumulation during cell cycle of Ehrlich ascites tumour cells.
    Skog S; Tribukait B
    Exp Cell Res; 1985 Aug; 159(2):510-8. PubMed ID: 4029278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth characteristics of anaerobically treated early and late S-period of Ehrlich ascites tumor cells after reaeration.
    Merz R; Schneider F
    Z Naturforsch C Biosci; 1983; 38(3-4):313-8. PubMed ID: 6868755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferation, macromolecular synthesis and energy metabolism of in vitro grown Ehrlich ascites tumor cells after inhibition of ATP-ADP translocation by atractyloside.
    Pick-Kober KH; Schneider F
    Eur J Cell Biol; 1984 Jul; 34(2):323-9. PubMed ID: 6090145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binucleate cells in the Ehrlich ascites tumor. Autoradiographic labeling.
    Pertusa J; Pellicer JA; Alcober V
    Biol Cell; 1989; 65(1):75-7. PubMed ID: 2706394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.